Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half

Norge Nyheter Nyheter

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half
Norge Siste Nytt,Norge Overskrifter
  • 📰 latimes
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 82%

Drugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus.

It may seem like biotech companies are focused solely on developing vaccines for COVID-19, but some are hard at work on drugs that could treat those who become sick.considered to be at higher risk for severe disease

An independent group of medical experts monitoring the trial recommended stopping it early because the interim results were so strong. That is typical when early results so clearly show a treatment works that there is no need for further testing before applying for authorization. Molnupiravir appears to work by disrupting the coronavirus’ ability to replicate itself inside of human cells. The drug tricks the virus into using its recipe for replication, then inserts a program that generates so many mutations, the virus quickly sputters and dies.

In the skeletal trial results released Friday, the red capsule showed no early signs of worrying side effects. Drug-related adverse events were seen in 12% of those taking molnupiravir and 11% of those who got placebo, Merck said. Just 1.3% of subjects taking the anti-viral medication withdrew from the trial due to worrying symptoms, along with 3.4% of those getting the placebo.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

latimes /  🏆 11. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorMerck COVID-19 pill success slams Moderna shares, shakes up healthcare sectorPositive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Les mer »

COVID-19 live updates: US death toll set to surpass 700,000COVID-19 live updates: US death toll set to surpass 700,000American Airlines told employees that all U.S.-based employees and certain international crew members must be vaccinated in light of the federal vaccine mandate.
Les mer »

Military suicide deaths increase but not seen as linked to COVID-19 pandemicMilitary suicide deaths increase but not seen as linked to COVID-19 pandemicThe Pentagon's annual report on suicides among military service members shows that while the number of deaths by suicide increased slightly from 2019 to 2020, there was no indication that the pandemic led to more deaths by suicide among service members.
Les mer »

California to be 1st state in nation to require COVID-19 vaccines for school childrenCalifornia to be 1st state in nation to require COVID-19 vaccines for school childrenCalifornia Gov. Gavin Newsom announced that the state will require vaccines for all school children ages 12-17 once the FDA grants full approval, becoming the first state in the country to move forward on mandating vaccines for school children.
Les mer »

Here Are the Side Effects to Expect After Your COVID-19 Booster ShotHere Are the Side Effects to Expect After Your COVID-19 Booster ShotAccording to a new CDC study.
Les mer »

How Monoclonal Antibody Therapies Fight Covid-19Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. Here's how the therapies work and why they’re important for saving lives.
Les mer »



Render Time: 2025-03-14 06:33:03